Tag Archives: FSANZ; TGA

Independent Review of the Therapeutic Goods Advertising Framework: Recommendations

In 2018, the Hon Greg Hunt MP, Minister for Health, committed to a review of the impact of the new therapeutic goods advertising measures within two years from the commencement of the changes to the Therapeutic Goods Act 1989 to … Continue reading

Posted in Advertising, Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

A medical food for depression?

Neurofolin┬« (containing 15 mg of L-methylfolate calcium) is a self-declared food for special medical purposes promoted for dietary support of depression management. Advertisments claim that L-methylfolate is, “an active form of folate known to be deficient in individuals with depressive … Continue reading

Posted in Advertising, Complementary medicine, Food, Medicine policy | Tagged | 1 Comment